Adil Maarouf

Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin‐4 Antibody Diseases

Pierre Durozard, Audrey Rico, Clémence Boutière et al. · Annals of Neurology · 2019 · 165 citations

Life Sciences, Immunology, Pharmacotherapy +17

Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome

Christine Lebrun‐Frénay, Fabien Rollot, Lydiane Mondot et al. · JAMA Network Open · 2021 · 86 citations · Full text

Medicine, Neurology, Radiology +14

Depletion of brain functional connectivity enhancement leads to disability progression in multiple sclerosis: A longitudinal resting-state fMRI study

Anthony Faivre, Emmanuelle Robinet, Maxime Guye et al. · Multiple Sclerosis Journal · 2016 · 78 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?

Adil Maarouf, Audrey Rico, Clémence Boutière et al. · Neurology Neuroimmunology & Neuroinflammation · 2020 · 76 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

MSCopilot, a new multiple sclerosis self‐assessment digital solution: results of a comparative study versus standard tests

Élisabeth Maillart, Pierre Labauge, Mikaël Cohen et al. · European Journal of Neurology · 2019 · 64 citations

Medicine, Neurology, Rehabilitation Medicine +14